Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter Randomised Study Comparing the Efficacy of PegIFN-alfa2a Plus Placebo vs. PegIFN-alfa2a Plus Tenofovir for the Treatment of Chronic Delta Hepatitis-The Hep-Net International Delta Hepatitis Interventional Trial II (HIDIT-II)

Next Previous
Search
Trial Profile

A Multicenter Randomised Study Comparing the Efficacy of PegIFN-alfa2a Plus Placebo vs. PegIFN-alfa2a Plus Tenofovir for the Treatment of Chronic Delta Hepatitis-The Hep-Net International Delta Hepatitis Interventional Trial II (HIDIT-II)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary) ; Peginterferon alfa-2a
  • Indications Hepatitis D
  • Focus Therapeutic Use
  • Acronyms HIDIT-2; HIDIT-II
  • Sponsors Roche

    • Most Recent Events

    • 01 Aug 2023 Results (n=83) assessing Quality-of-life scores after 96 weeks of PEG-IFNa-2a treatment of hepatitis D published in the Liver International
    • 24 Jun 2023 Results (n=120) assessing Five years follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D presented at the European Association for the Study of the Liver Congress 2023
    • 26 Aug 2017 This trial has been completed in Germany as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top